Aesthetic Medical International Holdings Group Limited (AIH)
NASDAQ: AIH · IEX Real-Time Price · USD
0.375
-0.124 (-24.89%)
May 20, 2024, 12:16 PM EDT - Market open
Company Description
Aesthetic Medical International Holdings Group Limited provides aesthetic medical services in the People's Republic of China and Singapore.
The company offers surgical aesthetic treatments, such as eye surgery, rhinoplasty, breast augmentation, and liposuction; and non-surgical aesthetic treatments, including minimally invasive and energy-based treatments, which include laser, ultrasound, and radiofrequency treatments.
It also provides general healthcare and other aesthetic medical services, such as internal medicine, urology, gynecology, and obstetrics treatment services, as well as dentistry, dermatology, and hair loss treatment services.
The company was founded in 1997 and is headquartered in Shenzhen, the People's Republic of China.
Aesthetic Medical International Holdings Group Limited
Country | China |
Founded | 1997 |
IPO Date | Oct 25, 2019 |
Industry | Medical Care Facilities |
Sector | Healthcare |
Employees | 1,286 |
CEO | Dr. Pengwu Zhou |
Contact Details
Address: 4068 Qiaoxiang Road, Nanshan District Shenzhen, F4 518053 China | |
Phone | 917 609-0333 |
Website | ir.aihgroup.net |
Stock Details
Ticker Symbol | AIH |
Exchange | NASDAQ |
Fiscal Year | January - December |
Reporting Currency | USD |
IPO Price | $12.00 |
CIK Code | 0001757143 |
CUSIP Number | 00809M104 |
ISIN Number | US00809M1045 |
SIC Code | 8093 |
Key Executives
Name | Position |
---|---|
Dr. Pengwu Zhou | Co-Founder and Non-Executive Co-Chairman of the Board |
Chen Zhang | Executive co-chairman of the Board |
Ding Wenting | Co-Founder and Chief Marketing Officer |
Guanhua Wu | Chief Financial Officer |
Qing Hu | Chief Operating Officer |
Derrick Shi | Investor Relations Associate Director |
Dr. Yitao Zhou | Chief Medical Technique Officer |
Latest SEC Filings
Date | Type | Title |
---|---|---|
May 20, 2024 | 6-K | Report of foreign issuer |
Apr 25, 2024 | 6-K | Report of foreign issuer |
Apr 25, 2024 | 20-F | Annual and transition report of foreign private issuers |
Mar 8, 2024 | 6-K | Report of foreign issuer |
Dec 13, 2023 | 6-K | Report of foreign issuer |
Sep 22, 2023 | 20-F/A | Filing |
Sep 8, 2023 | 6-K | Report of foreign issuer |
Sep 5, 2023 | 6-K | Report of foreign issuer |
Aug 17, 2023 | SC 13D/A | [Amend] General statement of acquisition of beneficial ownership |
Aug 17, 2023 | SC 13D/A | [Amend] General statement of acquisition of beneficial ownership |